Eastvale Family Care Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14252 Schleisman Rd., Eastvale, CA 92880 Phone: 951-549-0900 Fax: 951-278-2848 |
Presto Concierge Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7044 Calina Ln, Eastvale, CA 92880 Phone: 630-532-3036 Fax: 630-596-0856 |
Omega Healthcare Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7121 Mackinaw Ct, Eastvale, CA 91752 Phone: 877-241-8200 Fax: 909-245-1751 |
Riverside Medical Clinic,inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12710 Limonite Ave, Eastvale, CA 91760 Phone: 951-683-6370 Fax: 951-248-6708 |
Crossover Health Medical Group Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 5379 Hamner Ave Unit 801, Eastvale, CA 91752 Phone: 949-891-0328 |
Eastvale Urgent Care Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 14252 Schleisman Rd, Eastvale, CA 92880 Phone: 951-549-0900 Fax: 951-278-2848 |
News Archive
President Obama nominated Dr. Vivek Murthy, a hospitalist at Harvard and an early supporter of the health law, to be the nation's surgeon general.
Five hundred cancer patients are getting an in-depth look at their genomes as part of a new clinical study that is revealing some of the key molecular drivers of metastatic cancers.
Johns Hopkins researchers report they have genetically engineered mice that display many of the behavioral hallmarks of human bipolar disorder, and that the abnormal behaviors the rodents show can be reversed using well-established drug treatments for bipolar disorder, such as lithium.
In making your pro-longevity resolutions, like drinking more red wine and maintaining a vibrant social network, here's one you likely forgot: dialing down your mitochondria. It turns out that slowing the engines of these tiny cellular factories could extend your life-an observation relevant not only to aging research but to our understanding of how cells communicate with each another.
MSD, known as Merck & Co., Inc. (NYSE: MRK) in the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development programme for omarigliptin, MSD's investigational treatment for type 2 diabetes.
› Verified 7 days ago